These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 38482977)

  • 1. A review on the new age methodologies for early detection of Alzheimer's and Parkinson's disease.
    Ghosh N; Sinha K; Sil PC
    Basic Clin Pharmacol Toxicol; 2024 May; 134(5):602-613. PubMed ID: 38482977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultrasensitive detection of blood biomarkers of Alzheimer's and Parkinson's diseases: a systematic review.
    Singh K; Cheung BM; Xu A
    Biomark Med; 2021 Dec; 15(17):1693-1708. PubMed ID: 34743546
    [No Abstract]   [Full Text] [Related]  

  • 3. miRNAs as Circulating Biomarkers for Alzheimer's Disease and Parkinson's Disease.
    Mushtaq G; Greig NH; Anwar F; Zamzami MA; Choudhry H; Shaik MM; Tamargo IA; Kamal MA
    Med Chem; 2016; 12(3):217-25. PubMed ID: 26527155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From Recognition to Remedy: The Significance of Biomarkers in Neurodegenerative Disease Pathology.
    Toader C; Dobrin N; Brehar FM; Popa C; Covache-Busuioc RA; Glavan LA; Costin HP; Bratu BG; Corlatescu AD; Popa AA; Ciurea AV
    Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Machine Learning and Digital Biomarkers Can Detect Early Stages of Neurodegenerative Diseases.
    Chudzik A; Śledzianowski A; Przybyszewski AW
    Sensors (Basel); 2024 Feb; 24(5):. PubMed ID: 38475108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morphometric and Nanomechanical Screening of Peripheral Blood Cells with Atomic Force Microscopy for Label-Free Assessment of Alzheimer's Disease, Parkinson's Disease, and Amyotrophic Lateral Sclerosis.
    Taneva SG; Todinova S; Andreeva T
    Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripheral Biomarkers for Early Detection of Alzheimer's and Parkinson's Diseases.
    Htike TT; Mishra S; Kumar S; Padmanabhan P; Gulyás B
    Mol Neurobiol; 2019 Mar; 56(3):2256-2277. PubMed ID: 30008073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unveiling New Strategies Facilitating the Implementation of Artificial Intelligence in Neuroimaging for the Early Detection of Alzheimer's Disease.
    Etekochay MO; Amaravadhi AR; González GV; Atanasov AG; Matin M; Mofatteh M; Steinbusch HW; Tesfaye T; Praticò D
    J Alzheimers Dis; 2024; 99(1):1-20. PubMed ID: 38640152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Artificial intelligence in Parkinson's disease: Early detection and diagnostic advancements.
    Reddy A; Reddy RP; Roghani AK; Garcia RI; Khemka S; Pattoor V; Jacob M; Reddy PH; Sehar U
    Ageing Res Rev; 2024 Aug; 99():102410. PubMed ID: 38972602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measuring Compounds in Exhaled Air to Detect Alzheimer's Disease and Parkinson's Disease.
    Bach JP; Gold M; Mengel D; Hattesohl A; Lubbe D; Schmid S; Tackenberg B; Rieke J; Maddula S; Baumbach JI; Nell C; Boeselt T; Michelis J; Alferink J; Heneka M; Oertel W; Jessen F; Janciauskiene S; Vogelmeier C; Dodel R; Koczulla AR
    PLoS One; 2015; 10(7):e0132227. PubMed ID: 26168044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glutamate Receptor Dysregulation and Platelet Glutamate Dynamics in Alzheimer's and Parkinson's Diseases: Insights into Current Medications.
    Gautam D; Naik UP; Naik MU; Yadav SK; Chaurasia RN; Dash D
    Biomolecules; 2023 Nov; 13(11):. PubMed ID: 38002291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Exosomes in the Pathogenesis and Theranostic of Alzheimer's Disease and Parkinson's Disease.
    He A; Wang M; Li X; Chen H; Lim K; Lu L; Zhang C
    Int J Mol Sci; 2023 Jul; 24(13):. PubMed ID: 37446231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomarkers for evaluation of clinical efficacy of multipotential neuroprotective drugs for Alzheimer's and Parkinson's diseases.
    Halperin I; Morelli M; Korczyn AD; Youdim MB; Mandel SA
    Neurotherapeutics; 2009 Jan; 6(1):128-40. PubMed ID: 19110204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent Evidence in Epigenomics and Proteomics Biomarkers for Early and Minimally Invasive Diagnosis of Alzheimer's and Parkinson's Diseases.
    Mayo S; Benito-León J; Peña-Bautista C; Baquero M; Cháfer-Pericás C
    Curr Neuropharmacol; 2021; 19(8):1273-1303. PubMed ID: 33357195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomarkers of Parkinson's disease: present and future.
    Miller DB; O'Callaghan JP
    Metabolism; 2015 Mar; 64(3 Suppl 1):S40-6. PubMed ID: 25510818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebrospinal Fluid Biomarkers for Target Engagement and Efficacy in Clinical Trials for Alzheimer's and Parkinson's Diseases.
    Parnetti L; Eusebi P; Lleó A
    Front Neurol Neurosci; 2016; 39():117-23. PubMed ID: 27463974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Links between COVID-19 and Parkinson's disease/Alzheimer's disease: reciprocal impacts, medical care strategies and underlying mechanisms.
    Huang P; Zhang LY; Tan YY; Chen SD
    Transl Neurodegener; 2023 Jan; 12(1):5. PubMed ID: 36717892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomarkers for the early detection of Parkinson's and Alzheimer's disease.
    Berg D
    Neurodegener Dis; 2008; 5(3-4):133-6. PubMed ID: 18322370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advanced glycation end products and protein carbonyl levels in plasma reveal sex-specific differences in Parkinson's and Alzheimer's disease.
    Sharma A; Weber D; Raupbach J; Dakal TC; Fließbach K; Ramirez A; Grune T; Wüllner U
    Redox Biol; 2020 Jul; 34():101546. PubMed ID: 32460130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Buntanetap, a Novel Translational Inhibitor of Multiple Neurotoxic Proteins, Proves to Be Safe and Promising in Both Alzheimer's and Parkinson's Patients.
    Fang C; Hernandez P; Liow K; Damiano E; Zetterberg H; Blennow K; Feng D; Chen M; Maccecchini M
    J Prev Alzheimers Dis; 2023; 10(1):25-33. PubMed ID: 36641607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.